BioGaia, Nestle infant formula
This article was originally published in The Tan Sheet
Executive Summary
BioGaia will provide Lactobacillus reuteri probiotic to Nestle Nutrition for use in infant formula products, the Stockholm, Sweden-based biotechnology firm says Aug. 21. BioGaia President Peter Rothschild credits the firm's probiotic safety data as "a strong factor in facilitating the agreement with Nestle," which has an existing partnership with BioGaia in the health care nutrition area. The infant formula deal will cover all world markets, excluding Korea and Japan, with an initial product launch planned for 2009